StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The stock has a market cap of $833,000.00, a PE ratio of 0.00 and a beta of -0.90. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99.
About Athersys
Featured Articles
- Five stocks we like better than Athersys
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Are Tariffs Threatening Disney’s Comeback Story?
- Basic Materials Stocks Investing
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
